Kari M Morrissey

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Renal transporters in drug development
    Kari M Morrissey
    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California 94158, USA
    Annu Rev Pharmacol Toxicol 53:503-29. 2013
  2. doi request reprint Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling
    Matthias B Wittwer
    University of California, San Francisco, Department of Bioengineering and Therapeutic Sciences RH 581, 1550 Fourth Street, San Francisco, California 94158, USA
    J Med Chem 56:781-95. 2013

Collaborators

  • Yong Huang
  • Matthias B Wittwer
  • Andrej Sali
  • Natalia Khuri
  • Alan Kosaka
  • Arik A Zur
  • Yasuto Kido
  • Xuexiang Zhang
  • Kathleen M Giacomini

Detail Information

Publications2

  1. doi request reprint Renal transporters in drug development
    Kari M Morrissey
    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California 94158, USA
    Annu Rev Pharmacol Toxicol 53:503-29. 2013
    ..Renal drug elimination in special populations and transporter splicing variants are also described...
  2. doi request reprint Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling
    Matthias B Wittwer
    University of California, San Francisco, Department of Bioengineering and Therapeutic Sciences RH 581, 1550 Fourth Street, San Francisco, California 94158, USA
    J Med Chem 56:781-95. 2013
    ..In parallel, a QSAR model identified distinct molecular properties of MATE1 versus OCT2 inhibitors and was used to screen the DrugBank in silico library for new hits in a larger chemical space...